Zhiguo Hou

1.6k total citations
46 papers, 675 citations indexed

About

Zhiguo Hou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine. According to data from OpenAlex, Zhiguo Hou has authored 46 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Complementary and alternative medicine. Recurrent topics in Zhiguo Hou's work include Metabolomics and Mass Spectrometry Studies (10 papers), Traditional Chinese Medicine Analysis (7 papers) and Chromatography in Natural Products (6 papers). Zhiguo Hou is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (10 papers), Traditional Chinese Medicine Analysis (7 papers) and Chromatography in Natural Products (6 papers). Zhiguo Hou collaborates with scholars based in China, Canada and United Kingdom. Zhiguo Hou's co-authors include Yubo Li, Yanjun Zhang, Zhenzhu Zhang, Ling‐Yi Kong, Haoyue Deng, Ju Liang, Lei Wang, Jian‐Guang Luo, Jingjing Fan and Chunhui Ni and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Zhiguo Hou

44 papers receiving 667 citations

Peers

Countries citing papers authored by Zhiguo Hou

Since Specialization

Citations

This map shows the geographic impact of Zhiguo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguo Hou more than expected).

Fields of papers citing papers by Zhiguo Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiguo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguo Hou. The network helps show where Zhiguo Hou may publish in the future.

Co-authorship network of co-authors of Zhiguo Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiguo Hou. A scholar is included among the top collaborators of Zhiguo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiguo Hou. Zhiguo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study 2025 ·BMC Medicine ·Zhenyu Lin, Peng Zhang, Ming Cai, Gang Li, Tao Liu, Kailin Cai, Jing Wang, Junli Liu, Hongli Liu, Weikang Zhang, Jinbo Gao, Chuanqing Wu, Linfang Wang, Zheng Wang, Zhiguo Hou, (unknown), Kaixiong Tao, Tao� Zhang	0
2	Camrelizumab plus apatinib in patients with advanced or recurrent endometrial cancer after failure of at least one prior systemic therapy (CAP 04): a single-arm phase II trial 2024 ·BMC Medicine ·Wenjuan Tian, (unknown), Jing Lü, Chuyu Jing, Wei Zhang, Haiming Li, Tingting Wang, Zhiguo Hou, (unknown), Wenqing Zhu, Yi Zhang, Boer Shan, Huijuan Yang, Xi Cheng, Huaying Wang	0
3	Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study 2023 ·Cancer Chemotherapy and Pharmacology ·Yuxiang Ma, Qun Chen, Yang Zhang, Jinhui Xue, Qianwen Liu, Yuanyuan Zhao, Yunpeng Yang, Yan Huang, Wenfeng Fang, Zhiguo Hou, Shaorong Li, Jing Wang, Li Zhang, (unknown)	1
4	Neoadjuvant short-course radiotherapy followed by chemotherapy plus camrelizumab versus long-course chemoradiotherapy followed by chemotherapy for patients with locally advanced rectal cancer: A randomized, multicenter, open-label phase 3 trial (Union). 2023 ·Journal of Clinical Oncology ·Zhenyu Lin, Peng Zhang, Zhiguo Hou, Kaixiong Tao, Tao� Zhang	1
5	Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial 2023 ·Translational Cancer Research ·Zhiguo Hou, (unknown), Xin Huang, Rosa A. Salcedo‐Hernández, (unknown)	1
6	Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma 2020 ·Annals of Translational Medicine ·Yanan Zheng, (unknown), Chao Yan, Min Yan, Zhiguo Hou, Rongrong Zheng, Zhenggang Zhu, Chen Li	14
7	Metabolomics study on primary dysmenorrhea patients during the luteal regression stage based on ultra performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry 2017 ·Molecular Medicine Reports ·Ling Fang, (unknown), Xinyu Liu, (unknown), Zhiguo Hou, (unknown), Jia Yin, (unknown), Yubo Li	19
8	A novel anti-lipopolysaccharide factor Sp ALF6 in mud crab Scylla paramamosain exhibiting different antimicrobial activity from its single amino acid mutant 2017 ·Developmental & Comparative Immunology ·Zhiguo Hou, Yuan Wang, Kai-Min Hui, Wenhong Fang, Shu Zhao, Jingxiao Zhang, Hongyu Ma, Xin-Cang Li	34
9	A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs 2016 ·Toxicological Sciences ·Yubo Li, Lei Wang, Ju Liang, Haoyue Deng, Zhenzhu Zhang, Zhiguo Hou, (unknown), Yuming Wang, Yanjun Zhang	26
10	A Novel Method for Evaluating the Cardiotoxicity of Traditional Chinese Medicine Compatibility by Using Support Vector Machine Model Combined with Metabonomics 2016 ·Evidence-based Complementary and Alternative Medicine ·Yubo Li, Haonan Zhou, (unknown), (unknown), Zhiguo Hou, Yanyan Xu, Yanjun Zhang	21
11	Metabonomic study of the effects of different acupuncture directions on therapeutic efficacy 2015 ·Journal of Chromatography B ·Ju Liang, (unknown), Jia Yin, Shizhe Deng, (unknown), Lei Wang, Haoyue Deng, Zhiguo Hou, Xiaofeng Zhao, (unknown), (unknown), Chao Zhang, Guang Tian, (unknown), Yubo Li	9
12	Rapid classification and identification of complex chemical compositions in traditional Chinese medicine based on UPLC-Q-TOF/MS coupled with data processing techniques using the KuDieZi injection as an example 2015 ·Analytical Methods ·Lei Yuan, Zhenzhu Zhang, Zhiguo Hou, Bin Yang, (unknown), Xuejun Guo, Yuming Wang, Yubo Li	23
13	A novel approach to the simultaneous extraction and non-targeted analysis of the small molecules metabolome and lipidome using 96-well solid phase extraction plates with column-switching technology 2015 ·Journal of Chromatography A ·Yubo Li, Zhenzhu Zhang, Xinyu Liu, (unknown), Zhiguo Hou, Yuming Wang, Yanjun Zhang	29
14	MUC5B promoter polymorphisms and risk of coal workers’ pneumoconiosis in a Chinese population 2014 ·Molecular Biology Reports ·Xiaoming Ji, (unknown), Kexin Jin, Chen Luo, Ruhui Han, (unknown), Zhiguo Hou, Jingjing Fan, Chunhui Ni	15
15	Serum miRNA profiling identifies miR-150/30a as potential biomarker for workers with damaged nerve fibers from carbon disulfide 2014 ·Industrial Health ·Li Guo, Chen Luo, Jingjing Fan, Zhiguo Hou, Xiaoming Ji, Feng Chen, Baoli Zhu, Chunhui Ni	3
16	Polymorphisms in SELE Gene and Risk of Coal Workers' Pneumoconiosis in Chinese: A Case-Control Study 2013 ·PLoS ONE ·Ting Wang, Xiaoming Ji, Chen Luo, Jingjing Fan, Zhiguo Hou, (unknown), Ruhui Han, Chunhui Ni	6
17	Genome-wide analysis of aberrantly expressed circulating miRNAs in patients with coal workers’ pneumoconiosis 2012 ·Molecular Biology Reports ·Li Guo, Xiaoming Ji, Sheng Yang, Zhiguo Hou, Chen Luo, Jingjing Fan, Chunhui Ni, Feng Chen	13
18	Polymorphisms in Inflammasome Genes and Risk of Coal Workers' Pneumoconiosis in a Chinese Population 2012 ·PLoS ONE ·Xiaoming Ji, Zhiguo Hou, Ting Wang, Kexin Jin, Jingjing Fan, Chen Luo, (unknown), Ruhui Han, Chunhui Ni	32
19	(±)-Praeruptorin A enantiomers exert distinct relaxant effects on isolated rat aorta rings dependent on endothelium and nitric oxide synthesis 2010 ·Chemico-Biological Interactions ·Xu Zhao, Xiaobing Wang, Yue Dai, Ling‐Yi Kong, Fengyun Wang, Huan Xu, Dan Lü, Jie Song, Zhiguo Hou	39
20	An application of high-speed counter-current chromatography coupled with electrospray ionization mass spectrometry for separation and online identification of coumarins from Peucedanum praeruptorum Dunn 2009 ·Journal of Chromatography B ·Zhiguo Hou, (unknown), Shun Yao, Jianguang Luo, Ling‐Yi Kong	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi Sun Breakdown of academic impact, for papers by Guohui Li Breakdown of academic impact, for papers by Diya Lv Breakdown of academic impact, for papers by Hongwei Fan Breakdown of academic impact, for papers by Chunhua Xia Breakdown of academic impact, for papers by Zhiyun Meng Breakdown of academic impact, for papers by Weiwei Li Breakdown of academic impact, for papers by Xia Tao